6998 fundamentals
An in-depth look to GENOR BIOPHARMA HLDGS LTD operating, investing, and financing activities
6998 free cash flow for H2 23 is -197.47 M HKD. For 2023, 6998 free cash flow was -470.9 M HKD and operating cash flow was -469.76 M HKD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
TTM